ArticleBlood cancer journal2025

Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia.

Hiroki Akiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.